Agena Bioscience Names Genelex as Certified Service Provider for Targeted Genetic Analysis
SAN DIEGO, Calif., August 29, 2016 – Agena Bioscience today announced the successful certification of Genelex as a Certified Service Provider of the MassARRAY® technology.
UNITED STATES DEPARTMENT OF VETERANS AFFAIRS AWARDS GENELEX FEDERAL SUPPLY SCHEDULE CONTRACT
Pharmacogenetic testing now available to improve complex medication management for veterans at risk of avoidable hospitalizations and ER visits
Seattle, WA—March 15, 2016 – Genelex, the More..
Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015
Seattle, WA June 03, 2015
On June 22, 2015, Medicare will begin denying coverage for the majority of genetic drug sensitivity (pharmacogenetic) testing that it has More..